New York-based private equity firm Hildred Capital Management announced on May 2 that it entered into an agreement to acquire AleraCare for an undisclosed price.
AleraCare is a provider of infusion and specialty pharmacy services. Founded in 2019, AleraCare’s core lines of business includes infusions at ambulatory infusion centers, home infusion therapy, specialty pharmacy and compounding pharmacy. It has more than 35 locations in the western United States.
Hildred Capital Management pursues growth equity investments in lower middle market healthcare companies with leading products, technologies and services.
AleraCare will use the capital provided by Hildred to further enhance its platform as it continues to grow its physical footprint, and advance physician-coordinated care standards through comprehensive and convenient infusion service offerings.
According to data captured in the LevinPro HC database, this acquisition marks the seventh specialty pharmacy transaction of the year. From January 1, 2022, through May 2, 2022, 12 specialty pharmacy acquisitions were reported.
